Johns Hopkins Medicine

Diabetes is known to cause increased risk for cardiovascular disease and many other health issues, so if you’ve been told you have prediabetes it’s important to stave off frank diabetes. Nas Mathioudakis, a diabetes expert at Johns Hopkins and one …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/monitoring-blood-sugar-is-important-when-youve-been-told-you-have-prediabetes-elizabeth-tracey-reports/"> <span class="screen-reader-text">Monitoring blood sugar is important when you’ve been told you have prediabetes, Elizabeth Tracey reports</span> Read More »</a></p>

Prediabetes is a condition where your blood sugar is higher than it should be, but not high enough to be called diabetes, and if you’ve been told you have it you can take steps to avoid transitioning to diabetes. That’s …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/can-you-avoid-developing-diabetes-if-you-have-prediabetes-elizabeth-tracey-reports/"> <span class="screen-reader-text">Can you avoid developing diabetes if you have prediabetes? Elizabeth Tracey reports</span> Read More »</a></p>

Heather Watson, nurse scientist for the Johns Hopkins Health System, interviews Kayla Van Boxtel and Christy Richter, two participants in the Nurse Scholar Fellowship, the Center for Nursing Inquiry’s program designed to build nursing expertise in inquiry work. Kayla and …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/episode-74-nurse-scholar-fellowship-building-expertise-in-nursing-inquiry-johns-hopkins-center-for-nursing-inquiry/"> <span class="screen-reader-text">Episode 74 – Nurse Scholar Fellowship: Building Expertise in Nursing Inquiry | Johns Hopkins Center for Nursing Inquiry</span> Read More »</a></p>

People who have prediabetes frequently go on to develop diabetes, but diabetes prevention programs or DPPs can help. Nas Mathioudakis, a diabetes expert at Johns Hopkins and one developer of an AI based DPP, explains what’s at stake. Nestoras Mathioudakis: …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/diabetes-prevention-programs-may-be-utilized-more-with-an-ai-approach-elizabeth-tracey-reports/"> <span class="screen-reader-text">Diabetes prevention programs may be utilized more with an AI approach, Elizabeth Tracey reports</span> Read More »</a></p>

Diabetes prevention programs or DPPs were developed by the CDC over a decade ago to help people with prediabetes avoid frank development of diabetes, but very few people access them. Nas Mathioudakis, a diabetes expert at Johns Hopkins and one …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/people-with-prediabetes-can-benefit-from-an-ai-based-diabetes-prevention-program-elizabeth-tracey-reports/"> <span class="screen-reader-text">People with prediabetes can benefit from an AI based diabetes prevention program, Elizabeth Tracey reports</span> Read More »</a></p>

For people with the condition called prediabetes, prevention to full blown diabetes is key. Over a decade ago the CDC developed diabetes prevention programs or DPPs to help but very few people access them. Now a new AI based DPP …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/how-does-ai-stack-up-against-human-provided-diabetes-prevention-programs-elizabeth-tracey-reports/"> <span class="screen-reader-text">How does AI stack up against human provided diabetes prevention programs? Elizabeth Tracey reports</span> Read More »</a></p>

Have you heard of ultrasensitive genetic testing for cancer? This method produces a very detailed characterization of someone’s tumor, and William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says it then may be used for subsequent decision …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/how-might-very-detailed-cancer-maps-inform-cancer-management-and-treatment-elizabeth-tracey-reports/"> <span class="screen-reader-text">How might very detailed cancer maps inform cancer management and treatment? Elizabeth Tracey reports</span> Read More »</a></p>

The genetic makeup of a cancer is quite different than that of the person who has it, and now new efforts to very specifically characterize the cancer are poised to have surveillance and treatment implications. That’s according to Kimmel Cancer …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/what-is-an-ultrasensitive-dna-test-in-cancer-elizabeth-tracey-reports/"> <span class="screen-reader-text">What is an ultrasensitive DNA test in cancer? Elizabeth Tracey reports</span> Read More »</a></p>

This month's topics include medical imaging and childhood cancers, low dose aspirin in colorectal cancer, AI and colonoscopy skills, and good news for women with early breast cancer.

Obtaining human organs for transplantation is largely managed by UNOS, the United Network for Organ Sharing, and it’s a not for profit enterprise. Yet Adam Schiavi, a neuro critical care expert at Johns Hopkins, says if current political forces have …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/should-the-complex-business-of-organ-transplantation-be-turned-over-to-a-private-enterprise-elizabeth-tracey-reports/"> <span class="screen-reader-text">Should the complex business of organ transplantation be turned over to a private enterprise? Elizabeth Tracey reports</span> Read More »</a></p>

Does the organ transplantation system in the US need reform? That’s the agenda of a disgruntled family member whose relative waited years for a transplant, in testimony before Congress, but Adam Schiavi, a neuro critical care expert at Johns Hopkins, …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/allowing-the-market-to-dictate-organ-transplantation-increases-inequity-elizabeth-tracey-reports/"> <span class="screen-reader-text">Allowing the market to dictate organ transplantation increases inequity, Elizabeth Tracey reports</span> Read More »</a></p>

UNOS, the United Network for Organ Sharing, oversees much of the organ transplantation taking place in the United States, and how it manages this is currently under attack, with some proponents arguing that the system should be replaced by one …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/would-an-organ-transplant-system-that-is-profit-driven-be-acceptable-elizabeth-tracey-reports/"> <span class="screen-reader-text">Would an organ transplant system that is profit driven be acceptable? Elizabeth Tracey reports</span> Read More »</a></p>

When it comes to organ transplantation one size does not fit all. A multitude of factors determine whether a given organ is right for a certain recipient, with at least one disgruntled family member challenging the system in Congress and …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/getting-an-organ-transplant-requires-a-number-of-factors-to-be-aligned-elizabeth-tracey-reports/"> <span class="screen-reader-text">Getting an organ transplant requires a number of factors to be aligned, Elizabeth Tracey reports</span> Read More »</a></p>

Is five years unacceptably long to wait on a transplant list for a donor heart? The son of a recipient thinks so, and is attempting to radically change our national organ transplant system. Johns Hopkins neuro critical care expert Adam Schiavi …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/how-are-special-interests-attempting-to-change-our-organ-donation-system-elizabeth-tracey-reports/"> <span class="screen-reader-text">How are special interests attempting to change our organ donation system? Elizabeth Tracey reports</span> Read More »</a></p>

Type 2 diabetes is one of the most common and often preventable conditions seen in primary care. In this episode of Medicine Made General, Dr. Nisa Maruthur explains what type 2 diabetes and prediabetes really mean, why many people don’t …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/living-well-with-or-preventing-type-2-diabetes-medicine-made-general/"> <span class="screen-reader-text">Ep 6: Living Well With — or Preventing — Type 2 Diabetes | Medicine Made General</span> Read More »</a></p>

Almost 400 million firearms are in civilian hands in the United States, a fact cited in the recently released JAMA Summit Report on Reducing Firearm Violence and Harms. Another is that firearms are involved in nearly 80% of homicides and …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/curtailing-firearm-violence-must-start-with-the-facts-elizabeth-tracey-reports/"> <span class="screen-reader-text">Curtailing firearm violence must start with the facts, Elizabeth Tracey reports</span> Read More »</a></p>

In our current AI boom, it can seem as if technology will soon take over our lives. Yet Joseph Sakran, one member of a multidisciplinary panel that has just published The JAMA Summit Report on Reducing Firearm Violence and Harms …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/what-is-the-role-of-technology-in-reducing-firearm-violence-elizabeth-tracey-reports/"> <span class="screen-reader-text">What is the role of technology in reducing firearm violence? Elizabeth Tracey reports</span> Read More »</a></p>

The JAMA Summit Report on Reducing Firearm Violence and Harms is a comprehensive document that’s just been released on the proceedings of a multidisciplinary panel convened to consider firearm violence from many perspectives. Trauma surgeon Joseph Sakran at Johns Hopkins …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/what-steps-are-needed-to-reduce-firearm-injuries-and-deaths-in-the-united-states-elizabeth-tracey-reports/"> <span class="screen-reader-text">What steps are needed to reduce firearm injuries and deaths in the United States? Elizabeth Tracey reports</span> Read More »</a></p>

The good news is in many cities around the United States deaths and injuries due to firearm violence appear to be trending down, and a new summit report published in the Journal of the American Medical Association may help continue …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/how-might-a-new-paradigm-reduce-firearm-violence-in-the-united-states-elizabeth-tracey-reports/"> <span class="screen-reader-text">How might a new paradigm reduce firearm violence in the United States? Elizabeth Tracey reports</span> Read More »</a></p>

Over 800,000 people have died since we entered this new century and 2 million plus have been injured using firearms in the United States. These daunting statistics underpin efforts by the American Medical Association and other organizations in creating a new …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/a-multifaceted-approach-is-being-taken-to-stem-firearm-violence-elizabeth-tracey-reports/"> <span class="screen-reader-text">A multifaceted approach is being taken to stem firearm violence, Elizabeth Tracey reports</span> Read More »</a></p>

This episode features Dr. Helen Hughes, Medical Director for the Office of Telemedicine at Johns Hopkins Medicine. She shares insights into the evolution of digital health and explores ways technology like virtual nursing and remote patient monitoring can support professional …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/making-care-better-how-telemedicine-supports-access-to-care-and-clinician-well-being-johns-hopkins-medicine-office-of-well-being/"> <span class="screen-reader-text">Ep: 19 Making care better: How telemedicine supports access to care and clinician well-being | Johns Hopkins Medicine Office of Well-Being</span> Read More »</a></p>

Federal officials have suggested that use of acetaminophen during pregnancy may increase the risk for autism in offspring. Heather Volk, an autism expert at Johns Hopkins, says use of acetaminophen may be a surrogate for something else. Volk: Could be …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/if-youre-pregnant-or-considering-pregnancy-should-you-take-acetaminophen-elizabeth-tracey-reports/"> <span class="screen-reader-text">If you’re pregnant or considering pregnancy, should you take acetaminophen? Elizabeth Tracey reports</span> Read More »</a></p>

Do women who take acetaminophen during pregnancy risk autism in their offspring? Autism expert Heather Volk at Johns Hopkins says one likely explanation is that taking the pain reliever during pregnancy is a stand in for another exposure that may …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/is-acetaminophen-use-during-pregnancy-associated-with-autism-in-offspring-elizabeth-tracey-reports/"> <span class="screen-reader-text">Is acetaminophen use during pregnancy associated with autism in offspring? Elizabeth Tracey reports</span> Read More »</a></p>

PM 2.5 stands for particulate matter 2.5 microns or less, and this category of air pollutant may well be involved in autism risk as well as cognitive issues in older adults. That’s according to Heather Volk, autism expert at Johns …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/a-certain-type-of-air-pollutant-seems-to-be-linked-to-brain-abnormalities-elizabeth-tracey-reports/"> <span class="screen-reader-text">A certain type of air pollutant seems to be linked to brain abnormalities, Elizabeth Tracey reports</span> Read More »</a></p>

A new study points to chemicals called PFAS in possibly underpinning autism development. Autism expert Heather Volk at Johns Hopkins says another environmental pollutant with a much more established record is the very minute particles found in the air called …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/can-air-pollution-impact-on-autism-elizabeth-tracey-reports/"> <span class="screen-reader-text">Can air pollution impact on autism? Elizabeth Tracey reports</span> Read More »</a></p>

Chemicals abbreviated PFAS have been used for some time in things like nonstick cookware, and almost all of us have measurable levels of them in our blood. Now a new study links maternal blood levels during pregnancy to changes in …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/pfas-exposure-during-pregnancy-may-cause-changes-in-the-developing-brain-elizabeth-tracey-reports/"> <span class="screen-reader-text">PFAS exposure during pregnancy may cause changes in the developing brain, Elizabeth Tracey reports</span> Read More »</a></p>

PFAS are chemicals that were used in things like nonstick cookware or stain resistant fabrics, and they’ve been implicated in a number of deleterious health outcomes, including autism. A new study looks at PFAS exposures in mothers and changes in …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/do-the-environmental-pollutants-pfas-have-any-impact-on-development-of-autism-elizabeth-tracey-reports/"> <span class="screen-reader-text">Do the environmental pollutants PFAS have any impact on development of autism? Elizabeth Tracey reports</span> Read More »</a></p>

Covid vaccines boosted the immune response in people being treated for cancer and improved their survival, a recent study concludes. mRNA expert Jeff Coller at Johns Hopkins says as more evidence mounts establishing the benefits of mRNA vaccines, we need …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/many-vaccines-are-intended-to-reduce-disease-severity-elizabeth-tracey-reports/"> <span class="screen-reader-text">Many vaccines are intended to reduce disease severity, Elizabeth Tracey reports</span> Read More »</a></p>

mRNA vaccines can help the body fight cancer, a new study found, yet when we look at what has been called ‘vaccine hesitancy’ we see many people are suspicious of vaccines in general, let alone mRNA vaccines. Johns Hopkins mRNA …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/why-were-so-many-people-hesitant-to-take-mrna-vaccines-elizabeth-tracey-reports/"> <span class="screen-reader-text">Why were so many people hesitant to take mRNA vaccines? Elizabeth Tracey reports</span> Read More »</a></p>

People with lung cancer and melanoma who were receiving immunotherapies and got a Covid vaccine saw dramatically improved survival compared with folks who did not get the vaccine, a recent study shows. mRNA expert Jeff Coller at Johns Hopkins muses …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/what-is-it-about-mrna-vaccines-that-helps-us-fight-cancer-elizabeth-tracey-reports/"> <span class="screen-reader-text">What is it about mRNA vaccines that helps us fight cancer? Elizabeth Tracey reports</span> Read More »</a></p>

People undergoing immunotherapy treatment for cancer and who got a Covid vaccine survived longer than those who did not get the vaccine, a new study finds. Jeff Coller, an mRNA expert at Johns Hopkins, examines why this hasn’t been seen …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/why-havent-we-seen-cancer-fighting-effects-with-vaccines-other-than-the-covid-vaccines-elizabeth-tracey-reports/"> <span class="screen-reader-text">Why haven’t we seen cancer fighting effects with vaccines other than the Covid vaccines? Elizabeth Tracey reports</span> Read More »</a></p>

If you were being treated for lung cancer or melanoma with immunotherapy and you received a Covid vaccine, you got a surprising benefit: you were twice as likely to survive your cancer as those who did not get a vaccine, …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/mrna-could-comprise-a-generic-vaccine-to-be-used-for-cancer-elizabeth-tracey-reports/"> <span class="screen-reader-text">mRNA could comprise a generic vaccine to be used for cancer, Elizabeth Tracey reports</span> Read More »</a></p>

People with lung cancer or melanoma who were receiving immunotherapy and got a Covid vaccine within 100 days of initiating treatment saw dramatically improved survival compared to those folks who did not receive a vaccine, a new study shows. mRNA …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/the-benefit-of-mrna-vaccines-in-cancer-treatment-is-ongoing-elizabeth-tracey-reports/"> <span class="screen-reader-text">The benefit of mRNA vaccines in cancer treatment is ongoing, Elizabeth Tracey reports</span> Read More »</a></p>

Combating cancer may soon include immunization with an mRNA vaccine, as studies accumulate demonstrating their benefit in revving up the immune system against the disease. mRNA expert Jeff Coller at Johns Hopkins says this is one way to engage your …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/mrna-vaccines-take-advantage-of-the-bodys-own-systems-elizabeth-tracey-reports/"> <span class="screen-reader-text">mRNA vaccines take advantage of the body’s own systems, Elizabeth Tracey reports</span> Read More »</a></p>

Receipt of an mRNA vaccine for Covid within 100 days of beginning immunotherapy for lung cancer or melanoma increased a person’s survival likelihood by a factor of two or greater, a new study shows. Johns Hopkins mRNA expert Jeff Coller …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/might-mrna-vaccines-replace-chemotherapy-for-cancer-treatment-elizabeth-tracey-reports/"> <span class="screen-reader-text">Might mRNA vaccines replace chemotherapy for cancer treatment? Elizabeth Tracey reports</span> Read More »</a></p>

mRNA vaccines saved millions of lives during the Covid-19 pandemic. Now a new study points to their effectiveness in helping people survive cancer. The study looked at people who received a Covid vaccine within 100 days of starting immunotherapy for …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/can-mrna-vaccines-treat-cancer-elizabeth-tracey-reports/"> <span class="screen-reader-text">Can mRNA vaccines treat cancer? Elizabeth Tracey reports</span> Read More »</a></p>

This episode of Vital Conversations features Dr. Steve Kravet, president of Johns Hopkins Community Physicians (JHCP), who discusses the organization’s growth and innovative strategies to enhance clinician well-being and retention. Access the podcast here. Have an idea for a podcast? Email [email protected].

Testing a fluid known as cerebrospinal fluid, or CSF, found surrounding the brain and spinal cord, reveals a lot about brain tumors and the immune response to them. Johns Hopkins neurosurgery department director Chetan Bettegowda and test developer says this …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/can-a-new-test-of-cerebrospinal-fluid-be-used-for-many-diseases-of-the-brain-and-spinal-cord-elizabeth-tracey-reports/"> <span class="screen-reader-text">Can a new test of cerebrospinal fluid be used for many diseases of the brain and spinal cord? Elizabeth Tracey reports</span> Read More »</a></p>

Tumor components and immune response indicators can be found in cerebrospinal fluid, or CSF, when someone has a brain tumor, in a new test developed by Chetan Bettagowda, director of neurosurgery at Johns Hopkins and one of the test’s developers. …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/cerebrospinal-fluid-may-hold-the-keys-to-brain-cancer-identification-and-treatment-elizabeth-tracey-reports/"> <span class="screen-reader-text">Cerebrospinal fluid may hold the keys to brain cancer identification and treatment, Elizabeth Tracey reports</span> Read More »</a></p>

Your immune system has everything to do with how your body responds to cancer, and brain tumors are no exception. A new test aims to assess that along with characterizing the tumor itself. Chetan Bettegowda, director of neurosurgery at Johns …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/what-does-your-immune-response-have-to-do-with-brain-tumors-elizabeth-tracey-reports/"> <span class="screen-reader-text">What does your immune response have to do with brain tumors? Elizabeth Tracey reports</span> Read More »</a></p>

Your brain and spinal cord are floating in something called cerebrospinal fluid, or CSF, and when brain tumors develop they shed cells and cellular components into this fluid. A new test developed by director of neurosurgery Chetan Bettegowda at Johns …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/cerebrospinal-fluid-can-tell-lots-about-brain-tumors-elizabeth-tracey-reports/"> <span class="screen-reader-text">Cerebrospinal fluid can tell lots about brain tumors, Elizabeth Tracey reports</span> Read More »</a></p>

When someone is thought to have a brain tumor procedures to make the diagnosis may be risky or invasive, so a new test developed by Chetan Bettegowda, director of the department of neurosurgery at Johns Hopkins and colleagues is a …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/can-assessments-of-brain-cancers-be-done-with-cerebrospinal-fluid-elizabeth-tracey-reports/"> <span class="screen-reader-text">Can assessments of brain cancers be done with cerebrospinal fluid? Elizabeth Tracey reports</span> Read More »</a></p>

How does listening to patients transform cancer care? In part two of Medicine Made General’s conversation on cancer survivorship, Johns Hopkins researcher Claire Snyder, PhD, MHS, returns to explain how her work helps patients’ voices shape their care. She discusses …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/ep-5-part-2-the-power-of-the-patient-voice-in-cancer-care-medicine-made-general/"> <span class="screen-reader-text">Ep 5 Part 2: The Power of the Patient Voice in Cancer Care | Medicine Made General</span> Read More »</a></p>

In this episode of Medicine Made General, Johns Hopkins cancer survivorship researcher Claire Snyder, PhD, MHS, joins hosts Dr. Bimal Ashar and Katie Caviness-Crolley to explore what survivorship really means—and why it begins at diagnosis, not after treatment ends. Dr. Snyder discusses how …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/ep-5-part-1-caring-for-the-whole-person-through-cancer-beyond-medicine-made-general/"> <span class="screen-reader-text">Ep 5 Part 1: Caring for the Whole Person: Through Cancer & Beyond | Medicine Made General</span> Read More »</a></p>

AI assisted colonoscopy, where a computer helped interpret images seen during the procedure, resulted in endoscopists being less adept at recognizing precancerous lesions known as polyps, a recent study finds. Kimmel Cancer Center director William Nelson at Johns Hopkins comments. …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/when-you-have-screening-colonoscopy-should-you-worry-about-the-endoscopists-skills-elizabeth-tracey-reports/"> <span class="screen-reader-text">When you have screening colonoscopy should you worry about the endoscopist’s skills? Elizabeth Tracey reports</span> Read More »</a></p>

If you’ve been treated for early breast cancer your overall risk for recurrence is small, a new large, long term study finds. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says these risks can be pinned to …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/small-risks-of-recurrent-breast-cancer-may-exist-after-treatment-elizabeth-tracey-reports/"> <span class="screen-reader-text">Small risks of recurrent breast cancer may exist after treatment, Elizabeth Tracey reports</span> Read More »</a></p>

Women who’ve had early breast cancer and been treated can likely lay their worries about recurrence to rest, a new study concludes. Johns Hopkins Kimmel Cancer Center director William Nelson says that’s the conclusion of this very large, long term …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/most-women-whove-had-early-breast-cancer-are-not-at-high-risk-for-recurrence-elizabeth-tracey-reports/"> <span class="screen-reader-text">Most women who’ve had early breast cancer are not at high risk for recurrence, Elizabeth Tracey reports</span> Read More »</a></p>

People who’ve had colorectal cancer and have a known mutation should likely take aspirin to help prevent disease recurrence, according to a new study. The benefit of aspirin in preventing cancers has been shown before in the skin cancer melanoma, …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/aspirin-may-be-of-benefit-in-a-number-of-cancers-elizabeth-tracey-reports/"> <span class="screen-reader-text">Aspirin may be of benefit in a number of cancers, Elizabeth Tracey reports</span> Read More »</a></p>

People who’ve had colorectal cancer and who have a mutation known as PI3 kinase benefit from taking asprin to prevent recurrence, a new study shows. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, describes the findings. Nelson: There were …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/what-is-the-benefit-of-asprin-in-reducing-colorectal-cancer-recurrence-elizabeth-tracey-reports/"> <span class="screen-reader-text">What is the benefit of asprin in reducing colorectal cancer recurrence? Elizabeth Tracey reports</span> Read More »</a></p>

Transcript Using CT scanning in children should be limited, a recent study concludes, finding that about one in ten cancers in kids were likely related to imaging studies using ionizing radiation. Kimmel Cancer Center director William Nelson at Johns Hopkins …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/care-should-be-taken-when-using-ct-in-kids-elizabeth-tracey-reports/"> <span class="screen-reader-text">Care should be taken when using CT in kids, Elizabeth Tracey reports</span> Read More »</a></p>